Press Releases

• Akoya Biosciences and Enable Medicine: Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas More
• Akoya Biosciences: Expands Biopharma Service Portfolio With New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025 More
• Alcyone Therapeutics: Strategic Financing to Advance an Expanded Pipeline of Pediatric-Focused Precision Therapeutics for Severe Neurological Diseases More
• Anumana: Expands AI Platform From Diagnostic Solutions to the Full Continuum of Cardiovascular Care More
• Boston Scientific: Chief Financial Officer (CFO) Dan Brennan to Retire; Jon Monson, Senior Vice President, Investor Relations To Succeed Brennan More
• CereVasc: Receives FDA Breakthrough Device Designation for the eShunt System for Use in Pediatric Patients More
• DeuteRx: CEO Honored With Two Industry Awards for Entrepreneurial Success and Innovation in Biopharma R&D More
• Dyne Therapeutics: Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy More
• Everest Biolabs Launches Groundbreaking EV Research Tools at ISEV2025 in Vienna More
• Orphan Therapeutics Accelerator: Foundational Partnerships More
• Seaport Therapeutics: Presents New Preclinical Data on SPT-320 (Glyph Agomelatine) at the Society of Biological Psychiatry (SOBP) Annual Meeting More
• Sebela Pharmaceuticals: Positive Topline Results From Phase 3 TRIUMpH Program of Tegoprazan in GERD More
• Stellaromics: First Deployment of Pyxa Platform in Europe More
• Verastem Oncology: U.S. IND Clearance of VS-7375, Oral KRAS G12D (ON/OFF) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors More

Financial News

• Cultivarium: Will Develop Advanced Tools for Fungi and Archaea More
• Flagship Pioneering: Unveils Etiome to Pioneer Preemptive Healthcare More More More
  
• More on Genentech Trying Repertoire’s Immune Synapse Technology in Autoimmune Disease More*
  
• Thermo Fisher Scientific: Invests to Enhance U.S. Innovation and Support Customers’ Manufacturing More More* More*
• X4 Pharmaceuticals: Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More
• X4 Pharmaceuticals: Reverse Stock Split More
  

Media/Misc Coverage

• Harvard: Rewriting Genetic Destiny More
• More on Harvard Fighting Back With Lawsuit Against Trump Administration More*
• Petri Dish: Boston Scientific CFO Retires; Biotech Undergoes 1-for-20 Reverse Stock Split More*
• Psychedelics May Reverse Effects of Neuroimmune Interactions That Drive Fear Responses More
  
• Subscribe to LifeSci Startup for Updates on US Startups More

Companies

Career Center

• OPPORTUNITY: Chief Executive Officer More
  
• OPPORTUNITY: Chief Product Officer More
• OPPORTUNITY: Vice President, Digital Health Business Development More
• OPPORTUNITY: Chief Business Officer More
• OPPORTUNITY: Vice President, Finance More
• OPPORTUNITY: Director, Compliance & Quality Systems More
• OPPORTUNITY: West Coast Business Development Director More
• OPPORTUNITY: Chief Financial Officer More

Event Center

• LEAP HR: Life Sciences West April 22-24
  
• Life Science Innovation Northwest 2025 April 23-24
• Financial Literacy for Life Science Professionals (Boston) April 24
• Financial Literacy for Life Science Professionals (New York City) April 24
• Milken Institute Global Conference May 4-7
• Seattle Life Sciences Conference May 6
• 2025 JLABS Investor & Partnering Day May 7
• 2025 PEGS Boston Summit May 12-16
• STAT Breakthrough Summit West May 14
• Digital Healthcare Innovation Summit May 19-20

Boston Sponsors